Wako Diagnostics Press Release - July 29th, 2013 Wako Diagnostics granted Medical Device Licences from Health Canada for the μTASWako® i30 Immunoanalyzer, and AFP-L3 and DCP Assays for Liver Cancer Risk Assessment - L3 - Document - PDFSEARCH.IO

First Page		Document Content
Date: 2014-02-04 16:53:12 AFP-L3 Biomarker Hepatocellular carcinoma Alpha-fetoprotein Liver cancer Medicine Tumor markers Hepatology		Wako Diagnostics Press Release - July 29th, 2013 Wako Diagnostics granted Medical Device Licences from Health Canada for the μTASWako® i30 Immunoanalyzer, and AFP-L3 and DCP Assays for Liver Cancer Risk Assessment Add to Reading List Source URL: www.wakodiagnostics.com Download Document from Source Website File Size: 158,27 KB Share Document on Facebook

	An Insight into Tumor Markers DocID: 1uGab - View Document
	Metabolic programming establishes resistance of oxidative-type skeletal muscles to glucocorticoid-induced muscle cachexia in rats DocID: 1rhZM - View Document
	Outlaw Human Gene Patents Because Human Genes Belong to Human Beings NOT Corporations. The US Supreme Court is currently considering the question DocID: 1qIXp - View Document
	Prostate Cancer Awareness What Is the Prostate? The prostate is a part of the male reproductive system. The prostate is located just below the bladder and in front of the rectum. It is about the size of a walnut and surr DocID: 1qiiR - View Document
	J Genet Counsel:263–288 DOIs10897REVIEW PAPER Predictors of Genetic Testing Decisions: A Systematic Review DocID: 1q8Cd - View Document